Press Release Details

Cerus to Present at Upcoming Investor Conferences in May

May, 06 2008

CONCORD, Calif.--(BUSINESS WIRE)--May 6, 2008--Cerus Corporation (NASDAQ:CERS) announced today that Company management will be presenting at two investor conferences in May. Conference information is as follows:

  • The Robert W. Baird Growth Stock Conference on Tuesday, May 13, 2008 at 12:15 p.m. EDT at the Four Seasons Hotel in Chicago, Illinois
  • The Seventh Annual JMP Securities Research Conference on Tuesday, May 20, 2008 at 2:00 p.m. EDT at the Ritz Carlton in San Francisco, California

Live webcasts of the presentations will be available on the investor relations section of the Company website at www.cerus.com. Replays will be available on the Company website for 14 days following the live event.

ABOUT CERUS

Cerus Corporation is a biomedical products company focused on commercializing the INTERCEPT Blood System to enhance blood safety. The INTERCEPT Blood System is designed to inactivate blood-borne pathogens in donated blood components intended for transfusion. Cerus currently markets the INTERCEPT Blood System for both platelets and plasma in Europe and the Middle East. The Company is also pursuing regulatory approvals in the United States and other countries. The INTERCEPT red blood cell system is currently in clinical development.

INTERCEPT and the INTERCEPT Blood System are trademarks of Cerus Corporation.

CONTACT: Cerus Corporation
William J. Dawson
VP, Finance & Chief Financial Officer
925-288-6053
or
Porter Novelli Life Sciences
Jason I. Spark, 619-849-6005

SOURCE: Cerus Corporation

    Global Headquarters

  • 1220 Concord Avenue
  • Concord, CA US 94520
  • +1 925.288.6000

    European Headquarters

  • Stationsstraat 79-D
  • 3811 MH Amersfoort, Netherlands
  • +31 (0) 33 49 60 600